Image Credit: Medcity News Announcement Sanofi’s Orano breakthrough radioligand therapy, Alphamedix, has successfully passed the efficacy test, meeting an excellent endpoint. Involving a cumulative response rate in its mid-stage study of ALPHAMEDIX-02. On the other side, Novartis, an...
Announcement The nChroma Bio, a leading genetic medicines company developing in vivo delivery of unique cargoes to address the limitations of the previous therapies, has received approval for its three abstracts, as well as the poster of distinction that will be officially confirmed at the ...
Image Credit: Swisscore Announcement Gain Therapeutics Inc., a leading clinical-level biotechnology company known for its development and exploratory-based next generation of allosteric small molecule therapies, has showcased the poster of parkinson’s disease and movement disorder at...
Image Credit: Medical Device Network Announcement Smith+Nephew, the leading medical technology business, is proud to introduce its new data created by Professor Amit Gefen and his research team, specifically mentioned on the public ground, with its publication in the International Wound Jo...
Image Credit: Bial Announcement Bial, a leading innovation-centric biopharmaceutical company targeting rare diseases and neurosciences, proudly mentioned its key progress in its current ACTIVATE (NCT05819359), phase 2 clinical trial examining the tolerability, efficacy, safety, pharmacokin...
Image Credit: Drug Discovery and Development Announcement OS Therapies Inc., a leading antibody drug conjugate and clinical-stage cancer immunotherapy biotechnology company has informed a regulatory update on its further plans for completing its marketing authorizations in the united kingdom (UK...
Image Credit: Pancreatic Cancer Action Network Announcement Oncolytics Biotech Inc., a leading clinical-stage immunotherapy company, is establishing pelareorep, which has prompted an update on its offered design of its intended registration-directed clinical trial in the first-line pancreatic du...
Image Credit: Indian Pharma Post Announcement AbbVie, a leading biotech company, has proceeded with its submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for tavapadon, a selective dopamine D1/D5 receptor partial agonist, which was previously studied as a on...
Image Credit: Symbiosys Capital Management Announcement The Clene Inc., and its fully owned subsidiary Clene Nanomedicine Inc., a leading clinical stage biopharmaceutical company that targets mitochondrial health improvement and provides a safe space for neuronal function, has unveiled its prese...
Image Credit: India Pharma Outlook Announcement Sandoz, a known leader in producing affordable medicines, has entered the US with its generic iron sucrose injection with the approval of the US Food and Drug Administration (FDA). The product is marketized and also ready for delivery and order thr...
